background
information
SADC
Regional Drug Control Programme [Dr Strijdom]
Background
to SADC
SADC comprises 14 member states having a combined population
of approximately 200 million persons. In March 1999 the SADC
Regional Drug Control Protocol (SRDCP) came into force.
SRDCP
Has the following objectives:
- To establish
appropriate and well functioning national and regional frameworks.
- To develop
and enhance basic capacities.
- To further
analyse the drug control situation in the SADC region.
Its main
areas of intervention are as follows:
- Regional
capacity building and coordination.
- National
capacity building and coordination.
- Legal
development.
- Supply
reduction.
- Demand
reduction.
- Illicit
drugs and HIV/AIDS.
Various
activities are indicated in the demand reduction area, including:
- Development
of integrated drug abuse prevention education and curriculum
development.
- Establishment
of SADC Epidemiological Network on Drug Use (SENDU).
- Training
of treatment and rehabilitation professionals.
- Development
of outreach programmes for vulnerable groups.
- Awareness
raising and prevention through mass media.
- Coordination
and support to NGOs.
- Research
on topics such as drug abuse and irresponsible sexual behaviour.
The 5-year
budget of SRDCP is approximately ,3.99 million from the European
Commission (EDF and EPRD-South Africa).
SADC
Drug Control Database
The main foci of this database are data on national contact
points, the drug control situation in different countries (seizures,
production, trafficking routes, trends, effects, mode of abuse,
and treatment and rehabilitation) and projects and programmes.
The main
problems with this database to date are that (i) data are often
not available, (ii) the data that is available is not always
relevant, (iii) too many authorities are involved in data collection,
and (iv) the questionnaire used is too complicated.
What is
required is better coordination with similar efforts by the
OAU and UNDCP, development of a simplified questionnaire, and
greater involvement of SADC Drug Control Committee (SDCC) members
in the collection and compilation of data.
Key findings
from the 1997 database are:
-
Alcohol
is by far the most abused drug, and is by far the drug that
causes the most problems.
- Cannabis
is the 2nd most abused drug and is the 2nd most damaging drug.
Cannabis abuse is stable or on the increase in all states
except among adult females in Zimbabwe. The area being cultivated
with cannabis is more than 2 158 hectares.
-
Heroin
is seen as a particularly serious problem in Mauritius, Botswana,
Swaziland, Tanzania, and Zambia.
- Namibia,
Zambia, and Zimbabwe report an increase in the abuse of opiates
in almost all age groups.
- When
reported, hallucinogens
and synthetics
are either stable or on the increase.
- Hypnotics
and sedatives are
stable or increasing in all countries except Zimbabwe.
- All
countries report intravenous abuse
of at least one or more illicit drugs.
The intention
is to link SENDU with the SADC Drug Control Database.
- Methaqualone
(Mandrax) is mentioned only as a problem in Namibia and South
Africa.
- Data
regarding the number of abusers receiving treatment is insufficient.
- 29 drug
control projects are being implemented.
Overview
of SENDU [Dr Parry]
Scientific
background
Three issues were mentioned as being major factors contributing
to the SENDU initiative:
- The
burden of harm from AOD use in Southern Africa is likely to
increase with development.
- Various
factors (globally, regionally and locally) have highlighted
the need for monitoring substance misuse in Southern Africa
at this time.
- The
SADC Protocol (1996) highlights the importance of information
and research to inform interdiction and demand reduction activities.
Article 6 (Law Enforcement, Point 2) states that Member States
shall 'establish a regional drug database' and Article 7 (Drug
Demand Reduction: Point E) states that Member States shall
provide and share systematic information and research data
on drug abuse, drug trafficking and demand reduction programmes
to facilitate regional cooperation and coordination.
The need
for accurate information on substance abuse trends is also important
as SADC member states seek to develop or modify existing drug
control strategies/master plans, and in particular as they seek
to develop and evaluate short term action plans (often at a
local level) to address substance abuse.
SENDU
Aims and Objectives
This is an observational epidemiology study.
Its purpose
is to develop, establish and evaluate a substance abuse sentinel
surveillance system in one or more sites in each of the 14 SADC
member states - building on the SACENDU model operational in
3 cities and 2 provinces in South Africa.
The overall
goal is to improve the information base for policy makers and
practitioners in SADC member states to address the health and
socio-economic burden caused by the misuse of AODs.
Specific
objectives include:
- Establishing
a network of key stakeholders in one or more sites (especially
major cities) in each of the 14 SADC member states, including
persons from the health, welfare, research, law enforcement
and education sectors.
- Reaching
agreement on a set of indicators for measuring the nature,
extent and effect of AOD use.
- Collecting
data on the AOD indicators at each of the sites.
- Sharing
and validating the information collected on an annual basis
at each site by running workshops involving key stakeholders.
- Preparing
reports on the nature, extent and effect of AOD use and changes
over time for each site, and an integrated report across sites.
- Disseminating
information to policy-makers and the general public to guide
programming and policy, and actively lobbying key decision
makers to use the information provided by this surveillance
system and to support its ongoing development.
- Evaluating
the project (externally).
Methods
Training (capacity
building) - through exposure to the SACENDU model and 3-4 day
intensive training (Consultation Meeting), as well as through
provision of written materials, site visits and attendance at
report back meetings.
Establishment
of site specific networks and implementation of a 'basic'surveillance
system in each and, if possible, additional components in some
sites. Site convenors will involve members of
the networks in collecting information on treatment demand (e.g.
from specialist treatment centres, if available, psychiatric
hospitals, PHC clinics) and on arrests/seizures. Where possible
assistance will be given to implementing more advanced surveillance
methods, such as high school surveys, emergency room studies,
mortuary studies, studies of AOD use among arrestees, and qualitative
research on drug users (e.g. sex workers and street children)
and other key informants. The project is to be phased-in in
two or more countries every 6 months.
Validate
and collate data. Validation is to largely take
place though discussions at (bi-) annual meetings that will
take place at each site. Collation will comprise the preparation
of site reports and their presentation at (bi) annual meetings.
The site reports will then be combined into regional reports
by the MRC.
Disseminate
findings. Findings will be reported annually
to the SDCC and written reports made available in paper format
and via the internet.
Evaluation.
Evaluation will be outsourced and will focus on both process
and outcome issues in terms of the following criteria: level
of participation of stakeholders, completeness and quality of
the information obtained, usefulness of the process and the
information obtained to network participants and policy-makers,
and appropriateness of indicators.
|